{"schema_version":"secwatch.filing_event.v1","accession":"0001628908-22-000129","form_type":"8-K","ticker":"EVH","cik":"0001628908","company_name":"Evolent Health, Inc.","filed_at":"2022-09-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:56.413878+00:00","generated_at":"2026-06-23T15:24:27.627038+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Evolent Health names Dan McCarthy as President; director Frank Williams not to stand for re-election","bullets":["Dan McCarthy, age 38, promoted to President effective Sept 15, 2022; continues as CEO of New Century Health.","Annual base salary increased to $460,000; eligible for bonus up to 175% of base.","Frank Williams will not stand for re-election at 2023 Annual Meeting; will continue as director until meeting.","Williams' decision not due to any disagreement with company operations, policies, or practices."],"urls":{"canonical":"https://secwatch.observer/filing/0001628908-22-000129","json":"https://secwatch.observer/filing/0001628908-22-000129.json","markdown":"https://secwatch.observer/filing/0001628908-22-000129.md","text":"https://secwatch.observer/filing/0001628908-22-000129.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1628908/000162890822000129/0001628908-22-000129-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1628908/000162890822000129/evh-20220901.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T15:24:27.627038+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"608a5ad39a","claim":"Frank Williams departed as Director at Evolent Health, Inc..","evidence_excerpt":"In addition, on September 6, 2022, the Company announced that Frank Williams has expressed his intent not to stand for re-election at the Company’s 2023 Annual Meeting.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890822000129/0001628908-22-000129-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"will not stand for re-election"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"7791814ff9","claim":"Dan McCarthy was named as President at Evolent Health, Inc..","evidence_excerpt":"On September 1, 2022, Evolent Health, Inc. (the “Company”) announced that Dan McCarthy has been named President of the Company, effective September 15, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890822000129/0001628908-22-000129-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"named"},{"label":"Role","value":"President"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}